Skip to content

Effects of mindfulness-based interventions on biomarkers in healthy and cancer populations: a systematic review.

Kenji Sanada, Marta Alda Díez, Montserrat Salas Valero, Maria C Perez-Yus, Marcelo Demarzo, Jesus Montero-Marin, Mauro Garcia-Toro, Javier García-campayo

BMC Complementary and Alternative Medicine February 23, 2017 DOI: 10.1186/s12906-017-1638-y (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Randomized Peer reviewed
Sample size 1,110
Population Healthy subjects and cancer patients
Intervention Mindfulness-based interventions (MBIs)
Topics Meditation
Keywords Biomarkers C-reactive protein Cytokines Interleukins Mindfulness-based interventions Neuropeptides
Key findings In healthy people, MBIs showed no effect on cytokines but appeared to raise IGF-1 levels, with possible benefits for stress recovery and CRP in lower-BMI individuals; in cancer patients, MBIs seemed to affect cytokine levels, possibly increasing IL-4 and decreasing IFN-γ, though the specific cytokines could not be determined. The authors describe the evidence as preliminary and call for additional randomized controlled trials.

Abstract

Only a small number of articles have investigated the relationship between mindfulness-based interventions (MBIs) and biomarkers. The aim of this systematic review was to study the effect of MBIs on specific biomarkers (cytokines, neuropeptides and C-reactive protein (CRP)) in both healthy subjects and cancer patients. A search was conducted using PubMed, EMBASE, PsycINFO and the Cochrane library between 1980 and September 2016. A total of 13 studies with 1110 participants were included. In the healthy population, MBIs had no effect on cytokines, but were found to increase the levels of the neuropeptide insulin-like growth factor 1 (IGF-1). With respect to neuropeptide Y, despite the absence of post-intervention differences, MBIs may enhance recovery from stress. With regard to CRP, MBIs could be effective in lower Body Mass Index (BMI) individuals. In cancer patients, MBIs seem to have some effect on cytokine levels, although it was not possible to determine which specific cytokines were affected. One possibility is that MBIs might aid recovery of the immune system, increasing the production of interleukin (IL)-4 and decreasing interferon gamma (IFN-γ). MBIs may be involved in changes from a depressive/carcinogenic profile to a more normalized one. However, given the complexity and different contexts of the immune system, and the fact that this investigation is still in its preliminary stage, additional randomized controlled trials are needed to further establish the impact of MBI programmes on biomarkers in both clinical and non-clinical populations.

Comparable studies

Other systematic reviews and meta-analyses on meditation, most cited first.

Study Year Design Participants
Meditation Programs for Psychological Stress and Well-being Diverse adult clinical populations 2014 Meta-analysis n = 3,515
Mindfulness-Based Stress Reduction for Stress Management in Healthy People: A Review and Meta-Analysis Healthy subjects 2009 Systematic review and meta-analysis
The psychological effects of meditation: A meta-analysis. Nonclinical groups of adult meditators 2012 Meta-analysis n = 163
Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse Adults with recurrent depression in full or partial remission 2016 Meta-analysis of individual patient data from randomized controlled trials n = 1,258
Mindfulness‐Based Stress Reduction and Mindfulness‐Based Cognitive Therapy – a systematic review of randomized controlled trials 2011 Systematic review

Citations in the library

Cited by 16

and 11 more in the library

Cites 17

and 12 more in the library

Explore topics